CMMB

Chemomab Therapeutics
CMMB

14 hedge funds and large institutions have $606K invested in Chemomab Therapeutics in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

41% less capital invested

Capital invested by funds: $1.03M → $606K (-$420K)

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$275K
2
+$212K
3
+$137K
4
XT
XTX Topco
Cayman Islands
+$50.4K
5
VF
Virtu Financial
New York
+$29K

Top Sellers

1
-$472K
2
-$229K
3
-$78.9K
4
Jane Street
Jane Street
New York
-$15.7K
5
IC
Ikarian Capital
Texas
-$3.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$171K
ACM
2
ADAR1 Capital Management
Texas
$132K
IC
3
Ikarian Capital
Texas
$85.5K
KPWS
4
Kestra Private Wealth Services
Texas
$85.3K
XT
5
XTX Topco
Cayman Islands
$31.4K
RhumbLine Advisers
6
RhumbLine Advisers
Massachusetts
$29.5K
Jane Street
7
Jane Street
New York
$25.7K
VF
8
Virtu Financial
New York
$18K
BNP Paribas Financial Markets
9
BNP Paribas Financial Markets
France
$13.4K
Morgan Stanley
10
Morgan Stanley
New York
$6.23K
GI
11
GAMMA Investing
California
$4.15K
UBS Group
12
UBS Group
Switzerland
$3.72K
SS
13
SBI Securities
Japan
$43
Northwestern Mutual Wealth Management
14
Northwestern Mutual Wealth Management
Wisconsin
$3
SFM
15
Sphera Funds Management
Israel
–
SCM
16
Stonepine Capital Management
Oregon
–